Mark W Hahn's Net Worth
$409 Million
Who is Mark W Hahn?
Mark W Hahn has an estimated net worth of $409 Million. This is based on reported shares across multiple companies, which include GIGABEAM CORP, CEMPRA, INC., Verona Pharma plc, ALSP Orchid Acquisition Corp I, and Dova Pharmaceuticals, Inc..
SEC CIK
Mark W Hahn's CIK is 0001408502
Past Insider Trading and Trends
2017 was Mark W Hahn's most active year for acquiring shares with 4 total transactions. Mark W Hahn's most active month to acquire stocks was the month of December. 2022 was Mark W Hahn's most active year for disposing of shares, totalling 10 transactions. Mark W Hahn's most active month to dispose stocks was the month of July. 2022 saw Mark W Hahn paying a total of $99,997.56 for 3,733,776 shares, this is the most they've acquired in one year. In 2021 Mark W Hahn cashed out on 3,090,112 shares for a total of $2,586,200.93, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GIGABEAM CORP No price found
CFO, VP Finance and Admin
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CEMPRA, INC. No price found
EVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verona Pharma plc (VRNA) Snapshot price: $26.39
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.90% | -129.67K |
$4.38 | -$568,386.66 | 14.29M |
Scheduled
|
Nov 1 - Nov 4
| ||
Form 4
| +5.52% | 754.05K |
$4.24 | -$1,043,131.62 | 14.42M |
Scheduled
|
Oct 30 - Nov 1
| ||
Form 4
| -1.05% | -144.56K |
$4.38 | -$632,760.99 | 13.67M |
Scheduled
|
Oct 24 - Oct 25
| ||
Form 4
| -3.67% | -525.77K |
$4.38 | -$2,303,772.76 | 13.81M |
Scheduled
|
Oct 18 - Oct 22
| ||
Form 4
| -4.02% | -600.00K |
$3.76 | -$2,254,080.00 | 14.34M |
Scheduled
|
Sep 11
| ||
Form 4
| -2.61% | -400.00K |
$3.20 | -$1,280,548.40 | 14.94M |
Scheduled
|
Aug 12 - Aug 13
| ||
Form 4
| +3.27% | 485.2K |
$2.62 | -$824,776.00 | 15.34M |
Aug 7
| |||
Form 4
| -0.59% | -88.54K |
$1.93 | -$171,005.03 | 14.94M |
May 1
| |||
Form 4
| -3.10% | -480.66K |
$2.29 | -$1,102,547.08 | 15.03M |
Feb 1
| |||
Form 4
| -4.96% | -809.01K |
$1.74 | -$1,410,748.15 | 15.51M |
Nov 1
| |||
Form 4
| +5.15% | 800K |
—
|
—
| 16.32M |
Oct 20
| |||
Form 4
| -1.75% | -275.89K |
$2.52 | -$693,897.03 | 15.52M |
Aug 3 - Aug 7
| |||
Form 4
| -1.12% | -179.65K |
$2.64 | -$474,938.45 | 15.8M |
Aug 1 - Aug 2
| |||
Form 4
| -2.77% | -455.53K |
$2.58 | -$1,173,394.58 | 15.98M |
May 1
| |||
Form 4
| -2.45% | -413.17K |
$2.56 | -$1,056,553.21 | 16.43M |
Scheduled
|
Feb 1
| ||
Form 4
| -3.44% | -600.00K |
$2.12 | -$1,269,060.00 | 16.85M |
Scheduled
|
Dec 20
| ||
Form 4
| -2.61% | -468.02K |
$1.60 | -$749,781.02 | 17.45M |
Scheduled
|
Nov 1
| ||
Form 4
| +25.15% | 3.6M |
—
|
—
| 17.91M |
Sep 26
| |||
Form 4
| -4.02% | -600.00K |
$1.75 | -$1,050,000.00 | 14.31M |
Scheduled
|
Aug 9
| ||
Form 4
| -3.04% | -468.02K |
$0.67 | -$315,105.63 | 14.91M |
Scheduled
|
Aug 1
| ||
Form 4
| -0.08% | -12.51K |
$0.50 | -$6,200.95 | 15.38M |
Scheduled
|
May 3
| ||
Form 4
| -2.73% | -432.13K |
$0.52 | -$225,786.88 | 15.39M |
May 1
| |||
Form 4
| -1.03% | -164.96K |
$0.77 | -$131,673.00 | 15.83M |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
| -2.83% | -465.26K |
$0.64 | -$297,824.16 | 15.99M |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -2.75% | -465.26K |
$0.78 | -$365,038.47 | 16.46M |
Scheduled
|
Aug 1 - Aug 2
| ||
Form 4
| -11.19% | -2.13M |
$0.89 | -$1,892,766.81 | 16.92M |
Scheduled
|
May 3
| ||
Form 4
| -0.14% | -26.73K |
$1.14 | -$30,571.49 | 19.05M |
Scheduled
|
Mar 1
| ||
Form 4
| +0.56% | 105.82K |
—
|
—
| 19.08M |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALSP Orchid Acquisition Corp I (ALOR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dova Pharmaceuticals, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.02K |
—
|
—
|
0
|
Nov 12
| |||
Form 4
| -7.91% | -775.00 |
$28.00 | -$21,700.00 | 9.02K |
Scheduled
|
Sep 30
| ||
Form 4
| -13.62% | -1.54K |
$14.17 | -$21,892.65 | 9.8K |
Scheduled
|
Jul 1
| ||
Form 4
| +353.76% | 8.84K |
—
|
—
| 11.34K |
Jan 4
| |||
Form 4
|
∞
| 2.5K |
$6.28 | $15,700.00 | 2.5K |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||